| Literature DB >> 31148503 |
Olena Gruzieva1,2, Cheng-Jian Xu3,4,5, Paul Yousefi6,7, Caroline Relton6,7, Simon Kebede Merid1, Carrie V Breton8, Lu Gao8, Heather E Volk9,10, Jason I Feinberg9, Christine Ladd-Acosta11, Kelly Bakulski11, Charles Auffray12, Nathanaël Lemonnier12,13, Michelle Plusquin14,15, Akram Ghantous16, Zdenko Herceg16, Tim S Nawrot14,17, Costanza Pizzi18, Lorenzo Richiardi18, Franca Rusconi19, Paolo Vineis15, Manolis Kogevinas20,21, Janine F Felix22,23, Liesbeth Duijts22,24, Herman T den Dekker22,23, Vincent W V Jaddoe22,23, José L Ruiz25,26, Mariona Bustamante20,21,25, Josep Maria Antó20,21,27, Jordi Sunyer20,21,27, Martine Vrijheid20,21, Kristine B Gutzkow28, Regina Grazuleviciene29, Carles Hernandez-Ferrer20,30, Isabella Annesi-Maesano31, Johanna Lepeule32, Jean Bousquet33,34, Anna Bergström1,2, Inger Kull1,35,36, Cilla Söderhäll37,38, Juha Kere38,39, Ulrike Gehring40, Bert Brunekreef40,41, Allan C Just42, Rosalind J Wright43, Cheng Peng44, Diane R Gold44,45, Itai Kloog46, Dawn L DeMeo44, Göran Pershagen1,2, Gerard H Koppelman3,4, Stephanie J London47, Andrea A Baccarelli48, Erik Melén1,36.
Abstract
BACKGROUND: Prenatal exposure to air pollution has been associated with childhood respiratory disease and other adverse outcomes. Epigenetics is a suggested link between exposures and health outcomes.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31148503 PMCID: PMC6792178 DOI: 10.1289/EHP4522
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Basic characteristics of cohorts included in the discovery EWAS meta-analysis.
| STUDY | Country | Enrollment period | Total | Selection criteria for EWAS | Air pollution exposure assessment | DNA methylation measurement | Study reference (PMID) | Study website |
|---|---|---|---|---|---|---|---|---|
| INMA | Spain | 1997–2008 | 3768 | available DNA from one of the subcohorts (Sabadell) | LUR | Illumina | 21471022 | |
| Generation R | Netherlands | 2002–2006 | 9901 | European, complete follow-up | LUR | Illumina | 23086283, 25527369 | |
| CHS | USA | 1995–1997 | 5341 | non-Hispanic white/Hispanic white | Outdoor air pollution monitoring stations in each of the study communities | Illumina | 16675435, 22896588 | |
| EARLI | USA | 2009–2012 | 232 | NA | used inverse distance-squared weighting | Illumina | 22958474 | |
| PRISM | USA | 2012–2014 | 592 | Random sample | hybrid land use regression and satellite-based model | Illumina | 24476840, 25328835 | NA |
| Project Viva | USA | 1999–2003 | 2128 | Available cord blood or early/mid-childhood blood sample | hybrid land use regression and satellite-based model | Illumina | 24639442 | |
| ENVIR | Belgium | 2010–2016 | 1210 | Random sample | spatial-temporal interpolation method | Illumina | 23742113 | |
| Piccolipiù | Italy | 2011–2015 | 3338 | Participants resident in the municipality of Turin with enough stored biological material and with 24-month follow-up data | LUR | Illumina | 24506846 | |
| Rhea | Greece | 2007–2008 | 1500 | Random sample | LUR | Illumina | 19713286 |
Figure 1.Manhattan plot for epigenome-wide meta-analysis of the association between (A) prenatal () and (B) prenatal exposure () and cord blood DNA methylation. Note: The solid horizontal line corresponds to an FDR rate of 0.05. Manhattan plot for : Six CpGs were considered statistically significant using FDR correction (red squares): cg15082635 in GNB2L1;SNORD96A, cg20340716 in USP43, cg00905156 in FAM13A, cg24127244 in SRPRB, cg06849931 in NOTCH4, and cg18640183 in P4HA2. Manhattan plot for : Fourteen CpGs were considered statistically significant using FDR correction (red squares): cg16811875 in PLXNA4, cg12193649 in ZNF705A, cg11886880 upstream of C14orf2, cg16253537 in FNIP1, cg12044654 in COL22A1, cg19120073 in TMCO3, cg05479174 in SFRS8, cg06846669 downstream of NEUROG1, cg23270359 in MRI1, cg01011943 in PSG5, cg00348551 in C7orf50, cg24709511 downstream of MORN1, cg22038738 in PLAT, and cg02236896 in ZNF695.
Statistically significant CpGs (FDR ) associated with IQR increases in prenatal () exposure and DNA methylation in newborns (discovery meta-analysis), and replication analyses in newborns, children (age 7–9 years) and adolescents (age 15–16 years).
| Chr | Position | CpG | Gene | Discovery: newborns | Replication: newborns | Replication: age 7–9 years | Replication: age 15–16 years | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ( | ALSPAC ( | BAMSE | HELIX ( | ALSPAC ( | BAMSE 16 years ( | ALSPAC 15 years ( | |||||
| Direction | |||||||||||
| 5 | 180670110 | cg15082635 | 0.001 (8.29E-08) | 0.0001 (0.75) | 0.0006 (0.02) | 0.00006 (0.05) | |||||
| 17 | 9559558 | cg20340716 | 0.0011 (0.50) | 0.0002 (0.89) | 0.0003 (0.19) | 0.0004 (0.15) | |||||
| 4 | 89744363 | cg00905156 | 0.001 (3.55E-07) | 0.0017 (0.03) | 0.0004 (0.15) | 0.0001 (0.72) | 0.00001 (0.90) | ||||
| 3 | 133524572 | cg24127244 | 0.001 (7.33E-07) | 0.0002 (0.61) | 0.00004 (0.42) | ||||||
| 6 | 32165893 | cg06849931 | 0.0003 (0.81) | 0.0022 (0.03) | 0.0010 (0.33) | 0.00002 (0.95) | |||||
| 5 | 131563610 | cg18640183 | 0.001 (1.80E-06) | 0.0003 (0.44) | 0.0006 (0.61) | 0.0009 (0.03) | 0.0001 (0.53) | 0.00001 (0.86) | |||
Note: , coefficient for methylation with an IQR increase in prenatal exposure; CHR, chromosome.
Discovery meta-analysis does not include the PRISM or Project Viva cohorts due to missing prenatal data.
Chromosomal position based on NCBI human reference genome assembly Build 37.
UCSC annotated gene.
Direction of methylation for each cohort included in the analysis (INMA, Generation R, CHS, ENVIRONAGE, Rhea, Piccolipiù, EARLI): , , .
Statistically significant CpGs (FDR ) associated with IQR increases in prenatal () exposure and DNA methylation in newborns (discovery meta-analysis), and replication in children (age 7–9 years) and adolescents (age 16 years).
| Discovery meta-analysis | Replication: age 7–9 years | Replication: age 16 years | ||||||
|---|---|---|---|---|---|---|---|---|
| Prenatal | BAMSE | HELIX ( | BAMSE ( | |||||
| Chr | Position | CpG | Gene | Direction | ||||
| 7 | 132192823 | cg16811875 | 0.0001 (0.86) | |||||
| 12 | 8324628 | cg12193649 | X | X | ||||
| 14 | 104376135 | cg11886880 | 0.0002 (0.50) | |||||
| 5 | 131132836 | cg16253537 | 0.001 (4.10E-07) | 0.00008 (0.43) | 0.0001 (0.63) | |||
| 8 | 139890342 | cg12044654 | 0.0004 (0.46) | 0.0001 (0.67) | ||||
| 13 | 114165365 | cg19120073 | ||||||
| 12 | 132239000 | cg05479174 | 0.0002 (0.87) | 0.0005 (0.44) | ||||
| 5 | 134879739 | cg06846669 | 0.00007 (0.77) | |||||
| 19 | 13875381 | cg23270359 | 0.00035 (0.01) | |||||
| 19 | 43690622 | cg01011943 | 0.003 (1.05E-06) | X | X | |||
| 7 | 1177965 | cg00348551 | 0.001 (1.13E-06) | 0.0008 (0.13) | 0.00010 (0.51) | |||
| 1 | 2251570 | cg24709511 | 0.0004 (0.23) | |||||
| 8 | 42064673 | cg22038738 | 0.0008 (0.39) | 0.0006 (0.32) | ||||
| 1 | 247169036 | cg02236896 | ||||||
Note: , coefficient for methylation with an IQR increase in prenatal exposure; CHR, chromosome.
Discovery meta-analysis does not include the Generation R cohort due to missing prenatal data.
Chromosomal position based on NCBI human reference genome assembly Build 37.
UCSC annotated gene.
Direction of methylation for each cohort included in the analysis (INMA, Project Viva, CHS, PRISM, ENVIRONAGE, Rhea, Piccolipiù, EARLI): , , .
DMRs in Relation to prenatal exposure that overlap between DMRcate and comb-p methods.
| DMRcate | Comb-p | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Chr | Start | End | No. of probes | Max | Gene | Start | End | No. of probes | ||
| 7 | 27169674 | 27171528 | 25 | 1.58E-03 | 9.20E-10 | 27169957 | 27171052 | 17 | 2.75E-12 | |
| 11 | 2019730 | 2021243 | 29 | 1.45E-03 | 6.75E-06 | 2020101 | 2020418 | 10 | 4.30E-04 | |
| 4 | 2366103 | 2367137 | 7 | 8.24E-04 | 6.05E-05 | 2366555 | 2367138 | 5 | 1.68E-05 | |
| 6 | 31963526 | 31964754 | 10 | 6.05E-05 | 31964193 | 31964392 | 5 | 2.42E-04 | ||
| 1 | 75198211 | 75199117 | 11 | 4.93E-04 | 1.25E-04 | 75198403 | 75198842 | 6 | 7.01E-03 | |
| 6 | 170596856 | 170598215 | 7 | 3.26E-04 | 170597326 | 170597589 | 4 | 2.96E-03 | ||
| 12 | 52400530 | 52401523 | 8 | 1.16E-04 | 5.36E-04 | 52400530 | 52400908 | 5 | 3.02E-03 | |
| 10 | 3823907 | 3825031 | 7 | 6.43E-04 | 3824387 | 3824688 | 4 | 7.18E-04 | ||
| 1 | 1549799 | 1550886 | 12 | 8.50E-04 | 1550648 | 1550887 | 8 | 6.48E-03 | ||
| 19 | 3970736 | 3971417 | 7 | 1.00E-03 | 3971119 | 3971418 | 5 | 3.60E-04 | ||
| 19 | 12876846 | 12877188 | 4 | 3.69E-03 | 2.65E-03 | 12876846 | 12877189 | 4 | 7.51E-04 | |
Fold change in DNA methylation .
Minimum FDR p-value for the region.
Annotated gene(s) in the region.
Sidak p-value.
Associations between PM exposure and gene expression levels in newborn children of the EARLI cohort ().
| Chr | Gene | ProbeID | LogFC | |
|---|---|---|---|---|
| Prenatal | ||||
| 4 | 16977925 | 0.025 | 0.57 | |
| 6 | 17017814 | 0.94 | ||
| 6 | 17027038 | 0.90 | ||
| 6 | 17029639 | 0.063 | 0.14 | |
| 6 | 17034630 | 0.63 | ||
| 6 | 17037128 | 0.018 | 0.51 | |
| 6 | 17039839 | 0.19 | ||
| 6 | 17042335 | 0.38 | ||
| 5 | 17119456 | 0.19 | ||
| 5 | 16999712 | 0.57 | ||
| 17 | 16831046 | 0.26 | ||
| 3 | 16945907 | 0.46 | ||
| Prenatal | ||||
| 7 | 17054312 | 0.001 | 0.98 | |
| 19 | 16876074 | 0.21 | ||
| 19 | 16872926 | 0.89 | ||
| 1 | 16701484 | 0.074 | 0.04 | |
| 10 | 16712773 | 0.022 | 0.45 | |
| 2 | 16893222 | 0.15 | ||
| 8 | 17081580 | 0.008 | 0.63 | |
| 12 | 16747907 | 0.11 | ||
| 5 | 16999631 | 0.27 | ||
| 7 | 17063005 | 0.17 | ||
| 13 | 16776883 | 0.32 | ||
| 8 | 17076726 | 0.26 | ||
| 1 | 16672635 | 0.21 | ||
| 19 | 16858849 | 0.26 | ||
Note: Results presented per increase in and increase in exposure for genes annotated to FDR significant CpGs in the discovery and EWAS. (one unit of the logFCs translates to a two-fold change in expression). Adjusted for sex, maternal smoking during pregnancy, and cell composition.
Associations between PM exposure and gene expression levels in 16-y-old children of the BAMSE cohort ().
| Chr | Gene | ProbeID | LogFC | |
|---|---|---|---|---|
| Concurrent | ||||
| 6 | TC6_mcf_hap5000165.hg.1 | 0.05 | 9.52E-05 | |
| 6 | TC6_apd_hap1000098.hg.1 | 0.06 | 9.73E-05 | |
| 6 | TC6_mann_hap4000155.hg.1 | 0.06 | 9.98E-05 | |
| 6 | TC6_cox_hap2000190.hg.1 | 0.05 | 1.03E-04 | |
| 6 | TC6_ssto_hap7000159.hg.1 | 0.05 | 1.10E-04 | |
| 6 | TC06001564.hg.1 | 0.05 | 1.31E-04 | |
| 6 | TC6_qbl_hap6000179.hg.1 | 0.05 | 1.42E-04 | |
| 17 | TC17000146.hg.1 | 0.05 | 4.98E-04 | |
| 4 | TC04001380.hg.1 | 2.14E-01 | ||
| 3 | TC03000725.hg.1 | 2.89E-01 | ||
| Concurrent | ||||
| 7 | TC07001077.hg.1 | 0.02 | 0.03 | |
| 19 | TC19001582.hg.1 | 0.02 | 0.06 | |
| 1 | TC01001369.hg.1 | 0.02 | 0.08 | |
| 1 | TC01006392.hg.1 | 0.01 | 0.08 | |
| 8 | TC08001675.hg.1 | 0.02 | 0.10 | |
| 8 | TC08001175.hg.1 | 0.02 | 0.16 | |
| 19 | TC19000239.hg.1 | 0.17 | ||
| 2 | TC02005015.hg.1 | 0.01 | 0.21 | |
| 10 | TC10001133.hg.1 | 0.01 | 0.29 | |
| 13 | TC13000425.hg.1 | 0.30 | ||
| 7 | TC07001877.hg.1 | 0.01 | 0.33 | |
| 19 | TC19001910.hg.1 | 0.96 | ||
Note: Results presented per increase in and increase in exposure for genes annotated to FDR significant CpGs in the discovery and EWAS. (one unit of the logFCs translates to a two-fold change in expression). Adjusted for sex, maternal smoking during pregnancy, active smoking at the time of biosampling, age at biosampling, municipality at birth, doctor’s diagnosis of asthma, and cell composition.